These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 10694190

  • 1. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [Abstract] [Full Text] [Related]

  • 2. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY.
    Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
    [Abstract] [Full Text] [Related]

  • 3. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
    Fedorova OV, Dorofeeva NA, Lopatin DA, Lakatta EG, Bagrov AY.
    Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
    [Abstract] [Full Text] [Related]

  • 4. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY, Fedorova OV.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [Abstract] [Full Text] [Related]

  • 5. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 6. Vasorelaxant effects of cicletanine and its (+)- and (-)-enantiomers in isolated human pulmonary arteries.
    Bagrov AY, Droy-Lefaix MT, Dmitrieva RI.
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1386-9. PubMed ID: 9832185
    [Abstract] [Full Text] [Related]

  • 7. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
    Pérez-Vizcaíno F, Villamor E, Duarte J, Tamargo J.
    Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
    [Abstract] [Full Text] [Related]

  • 8. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY.
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 10. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 11. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY.
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [Abstract] [Full Text] [Related]

  • 12. Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.
    Fedorova OV, Emelianov IV, Bagrov KA, Grigorova YN, Wei W, Juhasz O, Frolova EV, Marshall CA, Lakatta EG, Konradi AO, Bagrov AY.
    J Hypertens; 2015 Aug; 33(8):1602-10. PubMed ID: 26136067
    [Abstract] [Full Text] [Related]

  • 13. Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.
    Fedorova OV, Fadeev AV, Grigorova YN, Marshall CA, Zernetkina V, Kolodkin NI, Agalakova NI, Konradi AO, Lakatta EG, Bagrov AY.
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):436-442. PubMed ID: 31415452
    [Abstract] [Full Text] [Related]

  • 14. Effects of the antihypertensive agent, cicletanine, on noradrenaline release and vasoconstriction in perfused mesenteric artery of SHR.
    Nasa Y, Yoshida H, Urata M, Uchibayashi K, Tsunoda Y, Kamigata K, Takeo S.
    Br J Pharmacol; 1998 Feb; 123(3):427-34. PubMed ID: 9504383
    [Abstract] [Full Text] [Related]

  • 15. Involvement of protein kinase C and Na+/K+-ATPase in the contractile response induced by myricetin in rat isolated aorta.
    Jiménez R, Zarzuelo A, Galisteo M, Duarte J.
    Planta Med; 2002 Feb; 68(2):133-7. PubMed ID: 11859463
    [Abstract] [Full Text] [Related]

  • 16. Endothelium-derived endothelin-1 reduces cerebral artery sensitivity to nitric oxide by a protein kinase C-independent pathway.
    Gilbert P, Tremblay J, Thorin E.
    Stroke; 2001 Oct; 32(10):2351-5. PubMed ID: 11588325
    [Abstract] [Full Text] [Related]

  • 17. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
    Fedorova OV, Ishkaraeva VV, Grigorova YN, Reznik VA, Kolodkin NI, Zazerskaya IE, Zernetkina V, Agalakova NI, Tapilskaya NI, Adair CD, Lakatta EG, Bagrov AY.
    Int J Mol Sci; 2018 Aug 13; 19(8):. PubMed ID: 30104471
    [Abstract] [Full Text] [Related]

  • 18. Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.
    Agalakova NI, Grigorova YN, Ershov IA, Reznik VA, Mikhailova EV, Nadei OV, Samuilovskaya L, Romanova LA, Adair CD, Romanova IV, Bagrov AY.
    Int J Mol Sci; 2022 Mar 19; 23(6):. PubMed ID: 35328757
    [Abstract] [Full Text] [Related]

  • 19. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.
    Fedorova OV, Kashkin VA, Zakharova IO, Lakatta EG, Bagrov AY.
    J Hypertens; 2012 Sep 19; 30(9):1817-26. PubMed ID: 22796708
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms underlying the contractile response to endothelin-1 in the rat renal artery.
    Callera GE, Bendhack LM.
    Pharmacology; 2003 Jul 19; 68(3):131-9. PubMed ID: 12784084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.